润都股份：获得沙库巴曲缬沙坦钠片药品注册证书

Core Viewpoint - The company, Rundu Co., has recently received two drug registration certificates for Sacubitril/Valsartan Sodium Tablets from the National Medical Products Administration [1] Group 1 - The issuance of the drug registration certificates indicates a significant regulatory approval milestone for the company [1] - Sacubitril/Valsartan is a medication used for treating heart failure, which may enhance the company's product portfolio and market presence [1]